Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …

Thyroid cancers (TCs) are the most common tumors of the endocrine system and a constant
rise in the number of TC cases has been observed for the past few decades. TCs are one of …

Objectives Anaplastic thyroid carcinoma (ATC) has a poor survival. The combination of
Dabrafenib plus Trametinib (DT) had a significant impact in survival of BRAF p. V600E …

B-Raf proto-oncogene serine/threonine-protein kinase (BRAF) is frequently altered in
multiple cancer types, and BRAF V600 mutations act as a prime target for precision therapy …

Thyroid carcinoma is a common malignant tumor of endocrine system and head and neck.
Recurrence, metastasis and high malignant expression after routine treatment are serious …

Anaplastic thyroid carcinoma (ATC) are highly aggressive malignant tumors with poor
overall prognosis despite multimodal therapy. As ATC are extremely rare, no randomized …

Objective Anaplastic thyroid cancer (ATC) is one of the most lethal human cancers with
meager treatment options. We aimed to identify the targeted drugs already approved by the …

Background Lenvatinib has shown promising efficacy in targeted therapies that have been
tested to treat anaplastic thyroid carcinoma (ATC) in both preclinical and clinical studies. The …

Background Anaplastic thyroid carcinoma has a very poor prognosis. We analyzed the effect
of surgery, radiotherapy and chemotherapy on survival time and side effects in patients with …

Background: Anaplastic thyroid carcinoma (ATC) is a highly invasive malignant tumor with a
poor prognosis. Traditional treatment methods have not been effective. However …